dc.contributor.author | Courtney MJ | |
dc.contributor.author | Michel MC | |
dc.contributor.author | Akerman KEO | |
dc.contributor.author | Holmberg CI | |
dc.contributor.author | Kukkonen JP | |
dc.contributor.author | Bischoff A | |
dc.contributor.author | Nasman J | |
dc.date.accessioned | 2022-10-28T13:20:46Z | |
dc.date.available | 2022-10-28T13:20:46Z | |
dc.identifier.uri | https://www.utupub.fi/handle/10024/164516 | |
dc.description.abstract | The ability of cloned human alpha(2B)-adrenoceptors heterologously expressed in Sf9 cells and endogenous alpha(2B)-adrenoceptors in NG 108-15 neuroblastoma X glioma cells to couple to increase of intracellular Ca2+ was studied. Ca2+ increases in NG 108-15 cells were detectable but slight, whereas those in alpha(2B)-adrenoceptor-expressing Sf9 cells were greater. In the latter, the maximum Ca2+ increase correlated positively, and the EC50-value of noradrenaline negatively, with the receptor expression density. The order of potency of the agonists was D-medetomidine ([D]-4-[5]-[1-(2,3-dimethylphenyl)ethyl]-1H-imidazole) > noradrenaline approximate to clonidine > oxymetazoline, with clonidine and UK14,304 (5-bromo-N-[4,5-dihydro-1H-imidazole-2-yl]-6-quinoxalinamine) being weak partial agonists. In Sf9 cells Ca2+ increases consisted of concomitant mobilization from an intracellular store and influx of extracellular Ca2+. In these cells alpha(2B)-adrenoceptor stimulation also increased the inositol 1,4,5-trisphosphate mass. We conclude that alpha(2B)-adrenoceptors can couple to intracellular Ca2+ increases which may involve prior activation of phospholipase C. (C) 1998 Elsevier Science B.V. All rights reserved. | |
dc.publisher | ELSEVIER SCIENCE BV | |
dc.title | alpha(2B)-adrenoceptors couple to Ca2+ increase in both endogenous and recombinant expression systems | |
dc.identifier.urn | URN:NBN:fi-fe2021042716377 | |
dc.relation.volume | 363 | |
dc.contributor.organization | fi=Turun biotiedekeskus|en=Turku Bioscience Centre| | |
dc.contributor.organization-code | 2609201 | |
dc.converis.publication-id | 18494725 | |
dc.converis.url | https://research.utu.fi/converis/portal/Publication/18494725 | |
dc.format.pagerange | 74 | |
dc.format.pagerange | 65 | |
dc.identifier.jour-issn | 0014-2999 | |
dc.okm.affiliatedauthor | Courtney, Michael | |
dc.okm.discipline | 1182 Biochemistry, cell and molecular biology | en_GB |
dc.okm.discipline | 1182 Biokemia, solu- ja molekyylibiologia | fi_FI |
dc.okm.internationalcopublication | international co-publication | |
dc.okm.internationality | International publication | |
dc.okm.type | Journal article | |
dc.relation.doi | https://doi.org/10.1016/S0014-2999(98)00780-8 | |
dc.relation.ispartofjournal | European Journal of Pharmacology | |
dc.relation.issue | 1 | |
dc.year.issued | 1998 | |